APA

Sorbe B. G., Högberg T., Glimelius B., Schmidt M., Wernstedt L., Hansen O., Sörensen B. T., Räisänen I., van Oosterom A. T. & de Bruijn K. M. (19940225). A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. : Cancer.

Chicago

Sorbe B G, Högberg T, Glimelius B, Schmidt M, Wernstedt L, Hansen O, Sörensen B T, Räisänen I, van Oosterom A T and de Bruijn K M. 19940225. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. : Cancer.

Harvard

Sorbe B. G., Högberg T., Glimelius B., Schmidt M., Wernstedt L., Hansen O., Sörensen B. T., Räisänen I., van Oosterom A. T. and de Bruijn K. M. (19940225). A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. : Cancer.

MLA

Sorbe B G, Högberg T, Glimelius B, Schmidt M, Wernstedt L, Hansen O, Sörensen B T, Räisänen I, van Oosterom A T and de Bruijn K M. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. : Cancer. 19940225.